Sign in

CIK 0000885590 · Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
operating
Phone
514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
  1. 4 Grant or award Director acquired 10,720 shares (grant or award)
  2. 4 Grant or award Director acquired 5,789 shares (grant or award)
  3. 4 Grant or award Director acquired 1,179 shares (grant or award)
  4. 4 Planned sale President, US Pharma sold 36,827 shares at $7.03 ($258,894)
  5. 4 Shares withheld for taxes President, US Pharma gave up 5,260 shares (to pay taxes)
  6. 4 Shares withheld for taxes President, US Pharma gave up 23,395 shares (to pay taxes)
  7. 4 Shares withheld for taxes SVP, Controller & CAO gave up 3,125 shares (to pay taxes)
  8. 4 Grant or award Director acquired 1,394 shares (grant or award)
  9. 4 Grant or award Director acquired 12,677 shares (grant or award)
  10. 4 Grant or award Director acquired 6,845 shares (grant or award)
  11. 4 Grant or award Director acquired 45,871 shares (grant or award)
  12. 4 Grant or award Director acquired 45,871 shares (grant or award)
  13. 4 Grant or award Director acquired 45,871 shares (grant or award)
  14. 4 Grant or award Director acquired 45,871 shares (grant or award)
  15. 4 Grant or award Director acquired 45,871 shares (grant or award)
  16. 4 Grant or award Director acquired 45,871 shares (grant or award)
  17. 4 Grant or award Director acquired 45,871 shares (grant or award)
  18. 4 Grant or award Director acquired 45,871 shares (grant or award)
  19. 4 Grant or award Director acquired 45,871 shares (grant or award)
  20. 4 Planned sale Director sold 24,456 shares at $5.43 ($132,796)

Page 1 of 61 · 1,214 filings